66 related articles for article (PubMed ID: 18051713)
1. [Clinical evaluation of the xMAP technology in detection of high-risk human papillomavirus].
Liao GD; Zhang XY; Gao YH; Liu B; Liu X; Li LK; Chen F; Bian ML; Chen W; Qiao YL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct; 29(5):603-7. PubMed ID: 18051713
[TBL] [Abstract][Full Text] [Related]
2. [Detection of multiple human papillomavirus infection in cervical specimens by flow fluorescent hybridization].
Chen QY; Bian ML; Zhang XY; Ou H; Ma L
Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(13):901-5. PubMed ID: 19671291
[TBL] [Abstract][Full Text] [Related]
3. An HPV 16, 18, and 45 genotyping test based on Hybrid Capture technology.
Thai H; Rangwala S; Gay T; Keating K; McLeod S; Nazarenko I; O'Neil D; Pfister D; Loeffert D
J Clin Virol; 2009 Jul; 45 Suppl 1():S93-7. PubMed ID: 19651375
[TBL] [Abstract][Full Text] [Related]
4. Validation of ThermoFisher's Papspin for human papillomavirus detection in cervicovaginal specimens using PCR with GP5+/GP6+ primers and the Hybrid Capture II assay.
Weynand B; Delvenne P; Polet R; Guiot Y; Arafa M; Somja J; Galant C
Clin Microbiol Infect; 2010 Jun; 16(6):671-5. PubMed ID: 19689463
[TBL] [Abstract][Full Text] [Related]
5. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.
Dalstein V; Merlin S; Bali C; Saunier M; Dachez R; Ronsin C
J Virol Methods; 2009 Mar; 156(1-2):77-83. PubMed ID: 19041893
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the f-HPV typing™ and Hybrid Capture II® assays for detection of high-risk HPV genotypes in cervical samples.
Cañadas MP; Cirigliano V; Darwich L; Sirera G; Coll J; Clotet B; Videla S
J Virol Methods; 2012 Jul; 183(1):14-8. PubMed ID: 22449759
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the PapilloCheck DNA micro-array Human Papillomavirus detection assay with Hybrid Capture II and PCR-enzyme immunoassay using the GP5/6+ primer set.
Jones J; Powell NG; Tristram A; Fiander AN; Hibbitts S
J Clin Virol; 2009 Jun; 45(2):100-4. PubMed ID: 19394266
[TBL] [Abstract][Full Text] [Related]
8. High-risk HPV detection in specimens collected in SurePath preservative fluid: comparison of ambient and refrigerated storage.
Hardie A; Moore C; Patnick J; Cuschieri K; Graham C; Beadling C; Ellis K; Frew V; Cubie HA
Cytopathology; 2009 Aug; 20(4):235-41. PubMed ID: 19659956
[TBL] [Abstract][Full Text] [Related]
9. The next-generation Hybrid Capture High-Risk HPV DNA assay on a fully automated platform.
Eder PS; Lou J; Huff J; Macioszek J
J Clin Virol; 2009 Jul; 45 Suppl 1():S85-92. PubMed ID: 19651374
[TBL] [Abstract][Full Text] [Related]
10. Detection of high-risk HPV types by the hybrid capture 2 test.
Terry G; Ho L; Londesborough P; Cuzick J; Mielzynska-Lohnas I; Lorincz A
J Med Virol; 2001 Sep; 65(1):155-62. PubMed ID: 11505458
[TBL] [Abstract][Full Text] [Related]
11. Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples.
Cibas ES; Hong X; Crum CP; Feldman S
Gynecol Oncol; 2007 Mar; 104(3):702-6. PubMed ID: 17150245
[TBL] [Abstract][Full Text] [Related]
12. Efficiency of the APTIMA HPV Assay for detection of HPV RNA and DNA targets.
Getman D; Aiyer A; Dockter J; Giachetti C; Zhang F; Ginocchio CC
J Clin Virol; 2009 Jul; 45 Suppl 1():S49-54. PubMed ID: 19651369
[TBL] [Abstract][Full Text] [Related]
13. [Study for association between high risk human papillomavirus and cervical lesions in the samples from opportunistic screening].
Bian LH; Li Y; Wang XL; Wu XZ; Song L; Liu HT
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Apr; 25(2):89-91. PubMed ID: 21863625
[TBL] [Abstract][Full Text] [Related]
14. Detection of high-risk human papillomavirus by two molecular techniques: hybrid capture and linear array.
de Antonio JC; Fernández-Olmos A; Mercadillo M; Lindemann ML; Mochales FB
J Virol Methods; 2008 Apr; 149(1):163-6. PubMed ID: 18328575
[TBL] [Abstract][Full Text] [Related]
15. Subvisual chromatin changes in cervical epithelium measured by texture image analysis and correlated with HPV.
Guillaud M; Adler-Storthz K; Malpica A; Staerkel G; Matisic J; Van Niekirk D; Cox D; Poulin N; Follen M; Macaulay C
Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S16-23. PubMed ID: 16188299
[TBL] [Abstract][Full Text] [Related]
16. Comparison between the Hybrid Capture 2 and the hpVIR real-time PCR for detection of human papillomavirus in women with ASCUS or low grade dysplasia.
Gustavsson I; Juko-Pecirep I; Backlund I; Wilander E; Gyllensten U
J Clin Virol; 2009 Jun; 45(2):85-9. PubMed ID: 19451022
[TBL] [Abstract][Full Text] [Related]
17. A novel method of HPV genotyping using Hybrid Capture sample preparation method combined with GP5+/6+ PCR and multiplex detection on Luminex XMAP.
Nazarenko I; Kobayashi L; Giles J; Fishman C; Chen G; Lorincz A
J Virol Methods; 2008 Dec; 154(1-2):76-81. PubMed ID: 18835300
[TBL] [Abstract][Full Text] [Related]
18. Comparison of a novel HPV test with the Hybrid Capture II (hcII) and a reference PCR method shows high specificity and positive predictive value for 13 high-risk human papillomavirus infections.
Baleriola C; Millar D; Melki J; Coulston N; Altman P; Rismanto N; Rawlinson W
J Clin Virol; 2008 May; 42(1):22-6. PubMed ID: 18262463
[TBL] [Abstract][Full Text] [Related]
19. The effect of different DNA isolation methods on the outcome of high-risk HPV testing.
Oevestad IT; Janssen EA; Baak JP
Indian J Pathol Microbiol; 2007 Oct; 50(4):733-9. PubMed ID: 18306539
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the Anyplex II HPV28 assay with the Hybrid Capture 2 assay for the detection of HPV infection.
Kwon MJ; Roh KH; Park H; Woo HY
J Clin Virol; 2014 Apr; 59(4):246-9. PubMed ID: 24568964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
